Close Menu


People in the News: Oct 6, 2010


Life Tech names Paul Billings chief medical officer; NanoString appoints Barry Saunders as chief commercial officer; Myconostica names David Evans as independent non-director.

Product Watch: Jul 15, 2010


NanoString ups nCounter multiplexing capabilities; Eppendorf launches divisible PCR plates; New England Biolabs introduces sample prep and master mix kits for Roche 454 sequencer library construction

People in the News: Jul 1, 2010


Fred Walder tapped as Fluidigm CBO; Andre Marion and Muneesh Tewari join WaferGen's SAB; NanoString appoints Brad Gray as CEO, Nalini Murdter as CBO

The CNV assays are the latest effort by NanoString to ferret out new applications for its nCounter platform, which the company initially developed as an alternative to both qPCR and microarrays for gene expression studies.

NanoString's nCounter gets ISO 13485:2003 certification; FDA clears Osmetech's eSensor thrombophilia risk test; PerkinElmer launches prenatal BACs-on-Beads assays in EU

The Seattle-based firm received ISO certification covering its nCounter multiplex molecular detection instrument and reagents.

Researchers from the University Health Network in Toronto, the Mayo Clinic, Ohio State University, and University of Miami School of Medicine are among the early-access customers who have been using the product ahead of its commercial launch this week.

NanoString Technologies

William Young said the firm's platform — which uses digital barcoding to enable multiplexed, direct profiling of individual molecules in a single reaction without amplification — is currently deployed for research purposes, but he sees a big opportunity in diagnostics and pharmacogenomics.

Pairings: Feb 10, 2010


William Young


A new analysis suggests warming, not the arrival of humans, led to the extinction of the woolly rhinoceros thousands of years ago, the Economist reports.

Chinese health officials uncovered SARS-CoV-2 viral RNA on imported frozen food, but the New York Times reports catching COVID-19 that way would be unlikely.

The UK has ordered 60 million coronavirus vaccine doses from Novavax and 30 million doses from Janssen, according to the Guardian.

In Science this week: machine learning model predicts whether ion channel mutations will cause disease, and more.